Both in Biotechnology
Century Therapeutics vs Lexeo Therapeutics
Over the past year IPSC returned +153.3% and LXEO returned −65.6%; their daily moves had a correlation of 0.29.
IPSC +153.3% LXEO −65.6%Growth of $1, one year, split-adjusted
| Metric | IPSC | LXEO |
|---|---|---|
| Price | $1.52 | $3.11 |
| Market cap | $275.2M | $255.3M |
| Today | +2.70% | +1.63% |
| 1 month | +2.7% | −8.8% |
| 6 months | −33.6% | −47.8% |
| Year to date | +52.8% | −68.7% |
| 1 year | +160.7% | −68.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $119.7M | $211.1M |
| Dividend yield | — | — |
| Volatility (60d) | 72.8% | 69.1% |
| Short % of float | 23.4% | 22.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).